Table 1.

Transfer of Escapee Tumor

Cells InjectedNo. of Dormant Mice/Total No. of Recipients (day to splenomegaly ± SD)
Nonimmune (control)ID-Immune*SCID + Anti-μVariant (0-4+)
BCL1 control 0/14 (28 ± 3) 19/28 (99 ± 47) ND  
Id-immune escapee no. 
0/5 (25 ± 0) 0/11 (47 ± 22) ND +++ 
0/5 (25 ± 0) 4/12 (67 ± 27) ND ++ 
0/5 (30 ± 0) 0/9 (30 ± 0) ND ++++ 
0/5 (47 ± 5) 5/10 (82 ± 43) ND 
2/5 (62 ± 8) 6/10 (79 ± 44) ND 
0/5 (28 ± 0) 1/9 (43 ± 16) ND +++ 
0/4 (29 ± 2) 6/10 (70 ± 33) ND 
0/5 (28 ± 0) 3/10 (44 ± 22) ND ++ 
SCID escapee no. 
0/5 (34 ± 6) 0/9 (36 ± 7) 0/10 (39 ± 2) ++++ 
10 0/5 (28 ± 0) 0/10 (33 ± 4) 0/10 (39 ± 2) ++++ 
Cells InjectedNo. of Dormant Mice/Total No. of Recipients (day to splenomegaly ± SD)
Nonimmune (control)ID-Immune*SCID + Anti-μVariant (0-4+)
BCL1 control 0/14 (28 ± 3) 19/28 (99 ± 47) ND  
Id-immune escapee no. 
0/5 (25 ± 0) 0/11 (47 ± 22) ND +++ 
0/5 (25 ± 0) 4/12 (67 ± 27) ND ++ 
0/5 (30 ± 0) 0/9 (30 ± 0) ND ++++ 
0/5 (47 ± 5) 5/10 (82 ± 43) ND 
2/5 (62 ± 8) 6/10 (79 ± 44) ND 
0/5 (28 ± 0) 1/9 (43 ± 16) ND +++ 
0/4 (29 ± 2) 6/10 (70 ± 33) ND 
0/5 (28 ± 0) 3/10 (44 ± 22) ND ++ 
SCID escapee no. 
0/5 (34 ± 6) 0/9 (36 ± 7) 0/10 (39 ± 2) ++++ 
10 0/5 (28 ± 0) 0/10 (33 ± 4) 0/10 (39 ± 2) ++++ 

Abbreviation: ND, not done.

*

The average day to splenomegaly of the escapees from Id-immune mice reinjected into Id-immune animals was compared with the average day to splenomegaly of control BCL1 in Id-immune animals. Five of 8 escapees had a statistically significant decrease in the average day to splenomegaly as determined by the Student's t-test (escapee no. 1 with P = .0013, escapee no. 2 with P = .018, escapee no. 3 with P = .0037, escapee no. 6 with P = .0002, and escapee no. 8 with P = .0001).

Estimation of susceptibility (0-4+) based on both proportion of dormant mice and interval before splenomegaly of challenged Id-immune recipient.

Close Modal

or Create an Account

Close Modal
Close Modal